-

Scott Gottlieb, M.D., Joins UnitedHealth Group Board of Directors

--(BUSINESS WIRE)--Dr. Scott Gottlieb, former U.S. Food and Drug Administration (FDA) commissioner, is joining UnitedHealth Group’s (NYSE: UNH) Board of Directors, effective immediately.

“I look forward to working with UnitedHealth Group to help shape how medical breakthroughs are developed and made accessible to patients who may benefit from them,” said Dr. Scott Gottlieb.

Share

Dr. Gottlieb, 53, served as FDA commissioner from 2017 to 2019, where he became known for promoting transparency, strengthening patient safety and widening consumer choice. He led initiatives to modernize regulations to help foster medical innovation, promote competition in the pharmaceutical market, confront the opioid epidemic and curb youth tobacco use.

“Scott has had an exceptional health care career in both the public and private sectors,” said Stephen J. Hemsley, UnitedHealth Group’s CEO and executive board chairman. “He is an innovator who constantly advocates for a more integrated health care approach supported by the latest technology. We welcome his deep expertise and thought leadership as we strive to help people live healthier lives and make the health system work better for everyone.”

In addition to his FDA service, Dr. Gottlieb has held roles at the Centers for Medicare & Medicaid Services and on the Federal Health Information Technology Policy Committee. A practicing physician, he is an elected member of the National Academy of Medicine and serves as a senior fellow at the American Enterprise Institute and a partner at New Enterprise Associates. He also contributes to CNBC and CBS News.

“I look forward to working with UnitedHealth Group to help shape how medical breakthroughs are developed and made accessible to patients who may benefit from them,” said Dr. Gottlieb. “I hope to leverage my experience to support providers in their delivery of care that’s not only more innovative but also more affordable, and that improves outcomes for patients and communities.”

About UnitedHealth Group

UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow UnitedHealth Group on LinkedIn.

Contacts

Media:
UnitedHealth Group Media
uhgmedia@uhg.com

UnitedHealth Group

NYSE:UNH

Release Versions

Contacts

Media:
UnitedHealth Group Media
uhgmedia@uhg.com

More News From UnitedHealth Group

UnitedHealth Group Recommends Shareholders Reject "Mini-Tender" Offer by Tutanota

--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today announced that it recently became aware of an unsolicited “mini-tender” offer by Tutanota LLC (Tutanota) to purchase up to 175,000 shares of UnitedHealth Group’s common stock, representing significantly less than 1% of UnitedHealth Group’s common stock outstanding. The offer price of $325.00 per share is conditioned on, among other things, the closing price per share of UnitedHealth Group’s common stock exceeding $325.00 per share on the l...

UnitedHealth Group Announces Leadership Transition

--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty’s decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company’s Board of Directors and Witty will serve as a senior adviser to Hemsley. “We are grateful for Andrew’s stewardship of UnitedHealth Group, especially during some of the most cha...

UnitedHealth Group Statement Regarding Medicare Advantage

--(BUSINESS WIRE)--The Wall Street Journal continues to report misinformation on the Medicare Advantage (MA) program. The government regularly reviews all MA plans to ensure compliance and we consistently perform at the industry’s highest levels on those reviews. We are not aware of the “launch” of any “new” activity as reported by the Journal. We are aware, however, that the Journal has engaged in a year-long campaign to defend a legacy system that rewards volume over keeping patients healthy...
Back to Newsroom